Released on = June 4, 2007, 10:22 am

Press Release Author = Synergy Research Group

Industry = Pharmaceuticals

Press Release Summary = According to Synergy Research Group, a Russia-based CRO, the
growth in the number of clinical trials approved by the Russian Federal Agency for
Health Care and Social Development (Roszdravnadzor) made up to nearly 40% in the 1st
Quarter of 2007 as compared to the same quarter of the previous year. At the same
time, the share of clinical studies initiated by Russian manufacturers has
increased.

Press Release Body = On June 03, 2007 Synergy Research Group, a Russia-based CRO,
presented the current issue of its Orange Paper, a regular analytical report on the
market of clinical trials in Russia. The formation of a civilized market of clinical
trials in Russia and improvement of the research attractiveness of Russia for
foreign sponsors as well as exoneration of clinical trials in the eyes of Russian
public are the key strategic objectives of Synergy Research Group.

According to the report, the growth in the number of clinical trials approved by the
Russian Federal Agency for Health Care and Social Development (Roszdravnadzor) made
up to nearly 40% in the 1st Quarter of 2007 as compared to the same quarter of the
previous year. At the same time, the share of clinical studies initiated by Russian
manufacturers has increased.

The report comprises four tables and seven figures reflecting different aspects of
the clinical trials market in Russia: balance between different phases and types of
clinical trials, shares of foreign and Russian sponsors, ratings of the leading
Russian and foreign pharmaceutical manufacturers, analysis of the leader's portfolio
and many other facts of interest.

The first issue of the Orange Book featuring the general picture of the Russian
clinical trials market as well as analysis of the studies conducted in Russia in
2006 was perceived with keen interest both in Russia and abroad. Experts from
foreign pharmaceutical companies, international contract research organizations and
foreign printed and online editions dealing with clinical studies gave high grades
to the first issue of the Orange Paper, and two of them applied to Synergy Research
Group for original articles on individual aspects of the Russian clinical trials
market.

The Orange Paper will be published in Russia in an electronic format on the Synergy
Research Group's official web page. New issues will also be published on the major
pharmaceutical and biotechnology information portals. The English version will be
distributed abroad on a subscription basis and published on popular sites covering
clinical trials.

Hard copies will be distributed at Russian and international exhibitions and
conferences devoted to clinical trials including the Clinical Studies of Drugs, the
6th International Conference, which will take place in Moscow on October 12, 2007,
and Partnership in Clinical Trials 2007 international conference scheduled for
November 5-8, 2007 in Amsterdam.

Synergy Research Group (SynRGT) is a Russian contract research organization, which
has been successfully operating all over Russia and the CIS member-states since
2002. SynRGT offers a broad range of services for conducting clinical trials for
Russian and foreign pharmaceutical and biotechnological companies - from
registration of the studies in regulatory authorities to pharmaco-economic surveys.
The company has its own clinical warehouse in Moscow, with the total area of 180
square meters. Today, Synergy Research Group is represented in Moscow,
Saint-Petersburg, Novosibirsk, Yekaterinburg and Almaty. The company's headquarters
are in Moscow.


Web Site = http://www.synrg-pharm.com/en/article11.htm

Contact Details = 14, Presnensky Val, 123557 Moscow, Russia
tel.: + 7 495 643 1186
E-mail: office@synrg-pharm.com